Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QLT PhotoTherapeutics (QLTI) -- Ignore unavailable to you. Want to Upgrade?

To: Julian who wrote (717)	11/10/1999 1:04:00 PM
From: Ian@SI	Read Replies (1) \| Respond to of 1321

At Yahoo Business News. ++++++++++ QLT Phototherapeutics Inc. (QLTI) 36 3/16 +1 11/16: ING Barings upgrades biotech firm from "buy" to "strong buy" as they see Visudyne on the market by as soon as year-end; recent price weakness creates buying opportunity..... -------------- QLT Photother. QLTI Warburg Dillon Read from Buy to Strong Buy _____________________ and today's headlines ______________ NEWS 11/10 11:22 QLT Photo. Maintained `Speculative Buy' at Nesbitt Burns 11/10 11:12 QLT Phototherapeutics Maintained `Strong Buy' at CIBC 11/10 10:26 QLT Phototherapeut. Reiterated `Strong Buy' at Adams, Harkness 11/10 10:16 QLT Photo Reiterated `Strong Buy' at Deutsche Bank AB 11/10 9:59 QLT Phototherapeutics Maintained `Hold' at TD Securities 11/10 9:22 QLT Phototherapeutics Raised to `Outperform' at RBC Dominion 11/10 8:55 QLT Phototherapeutics Raised to `Strong Buy' at ING Barings 11/10 7:47 QLT Phototherap. Raised to `Strong Buy' at Warburg Dillon ++++++++++++= Princeton, New Jersey, Nov. 10 (Bloomberg Data) -- QLTt Phototherapeutics Inc. (QLTI US) was raised to ``strong buy' from ``buy' by analyst Joseph P. Dougherty at Warburg Dillon Read Inc. The 12-month target price is $55.00 per share. ++++++++++++++ Princeton, New Jersey, Nov. 10 (Bloomberg Data) -- QLT Phototherapeutics Inc. (QLTI US) was raised to ``strong buy' from ``buy' by analyst Paul E. Kelly at ING Barings. +++++++++++++++ Toronto, Nov. 10 (Bloomberg Data) -- QLT Phototherapeutics Inc. (QLT CN) was raised to ``outperform' from ``neutral' by analyst Douglas Miehm at RBC Dominion Securities. The 12-month target price is C$61.50 per share. ++++++++++++ Toronto, Nov. 10 (Bloomberg Data) -- QLT Phototherapeutics Inc. (QLT CN) was maintained ``hold' by analyst Hari Sambasivam at TD Securities. The 12-month target price is C$48.50 per share. ++++++++++ Princeton, New Jersey, Nov. 10 (Bloomberg Data) -- QLT Phototherapeutics Inc. (QLTI US) was reiterated ``strong buy' by analyst Kevin C. Tang at Deutsche Banc Alex. Brown. +++++++++++ Princeton, New Jersey, Nov. 10 (Bloomberg Data) -- QLT Phototherapeutics Inc. (QLTI US) was reiterated ``strong buy' by analyst Carol Werther at Adams, Harkness & Hill. The 12-month target price is $59.00 per share. ++++++++++++++++++ Toronto, Nov. 10 (Bloomberg Data) -- QLT Phototherapeutics Inc. (QLT CN) was maintained ``strong buy' by analyst Lennox Gibbs at CIBC World Markets Inc.. The 12-month target price is C$79.00 per share. +++++++++++++++++ Toronto, Nov. 10 (Bloomberg Data) -- QLT Phototherapeutics Inc. (QLT CN) was maintained ``speculative buy' by analyst Christine Charette at Nesbitt Burns. The 12-month target price is C$87.50 per share.